ALLMedicine™ Insulinoma Center

Mar 6th, 2023 - 68 GaGa-DOTATATE PET/CT versus [68 Ga]Ga-Exendin-4 PET/CT in the evaluation of metastatic insulinoma.|2023|Guo W,Chen Y,He X,Fu H,Huang J,|

Mar 6th, 2023 - Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) is emerging as a safe and effective treatment for pancreatic neuroendocrine tumors. We aimed to compare EUS-RFA and surgical resection for the treatment of pancreatic insulinoma (PI). ...

Feb 24th, 2023 - Dextrose and glucose stimulators Class Summary Prompt gluconeogenesis is achieved with glucagon. Emergent blood glucose elevation requires intravenous dextrose. First-line agent for oral hypoglycemic toxicity is dextrose. Pancreatic alpha cells of...

Feb 21st, 2023 - The goal of this muticentre randomized controlled trial is to compare endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) with surgery for treatment of pancreatic insulinoma. The main questions it aims to answer are: 1) What is the safe...

Feb 14th, 2023 - Insulinomas are rare functional pancreatic neuroendocrine tumors. While most insulinomas are indolent and cured after surgery, 10-15% of cases show aggressive or malignant tumor behavior and metastasize locally or to distant organs. Patients with ...

Feb 21st, 2023 - The goal of this muticentre randomized controlled trial is to compare endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) with surgery for treatment of pancreatic insulinoma. The main questions it aims to answer are: 1) What is the safe...

Jan 5th, 2023 - The purpose of the current study will be to evaluate the usefulness of 68Ga-HA-DOTATATE compared to current standard anatomical imaging including CT, MRI, 111 In-pentetreotide Scans, 18F-FDG PET/CT, as available. Specifically, we aim to assess the...

Dec 12th, 2022 - Congenital Hyperinsulinism (HI) is a disorder of insulin secretion that causes profound hypoglycemia leading to significant morbidity. It is the most common form of persistent neonatal hypoglycemia, and the most dangerous. Inappropriate insulin se...

Oct 14th, 2022 - Insulinoma is the most common cause of endogenous hyperinsulinemic hypoglycemia in adult patients without diabetes. The only curative treatment of an insulinoma is its surgical removal. Therefore, exact preoperative localization of the insulinoma ...

Aug 31st, 2022 - The research contents of this study include: patients with insulinoma near the main pancreatic duct in the head and neck of the pancreas were randomly divided into two groups: the preoperative pancreatic duct stent enucleation group (stended EN), ...

Nov 18th, 2022 - The study covered in this summary was published in Research Square as a preprint and has not yet been peer reviewed. Key Takeaways Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) may be a less invasive alternative to resection of pa...

Aug 24th, 2021 - Prevalence of type 2 diabetes among American youth has nearly doubled over the past 20 years, a new study found. Since the turn of the century, the estimated prevalence of type 2 diabetes among Americans ages 10 to 19 years increased by a relative...

Apr 2nd, 2021 - Approximately 20% of pancreatic neuroendocrine tumors (NETs) are hormonally functional, meaning that the tumor produces a measurable hormone that results in a clinical syndrome, states Jonathan R. Strosberg, MD. Examples include: VIPoma, producing...

Dec 20th, 2020 - Combining the chemotherapy streptozotocin with drugs that target the mTOR pathway may be an effective way to treat pancreatic neuroendocrine tumors (pNETs), according to findings presented at the 2015 North American Neuroendocrine Tumor Society sy...

Dec 5th, 2020 - Approximately 175,000 Americans are affected by neuroendocrine tumors (NETs), 65% of which are gastroenteropancreatic (GEP) NETs. GEP-NETs represent a diverse family of tumors that arise in the gastrointestinal (GI) tract or pancreas.1-3 The overa...